Clinical Trial Update: The Effect Of Acadesine On Reducing Cardiovascular and Cerebrovascular Adverse Events In Coronary Artery Bypass Graft (CABG) Surgery (Study P05633 AM1)(TERMINATED) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating acadesine for reducing cardiovascular and cerebrovascular adverse events in patients undergoing coronary artery bypass graft surgery …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Left Ventricular Dysfunction
• Myocardial Infarction
• Stroke

Drugs mentioned

• Acadesine

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Coronary Artery Bypass, Myocardial Infarction | Phase 3 | Status: TERMINATED | Results posted: 2012-12-20